A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Annals of the Rheumatic Diseases

Topics

Medicine

Internal Medicine

Gastroenterology

Rheumatology

Genetics

Show all topics

DOI

10.1136/annrheumdis-2012-203091

License

CC-BY-NC

Other Formats

PDF